Phase 3 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with primary or recurring ovarian cancer, fallopian tube cancer, or primary peritoneal cancer
- People who are scheduled to have debulking or cytoreductive surgery (surgery to remove as much of the tumour as possible)
- People where the surgical team suspects a section of the lower bowel (the rectosigmoid) may need to be removed during the debulking surgery
- People who have agreed to take part and signed a consent form before the operation takes place
- People who have had the rectosigmoid section of the bowel removed during surgery
- People whose surgeon plans to reconnect the bowel (called a colorectal anastomosis) during the same operation
Who may not be able to join:
- People who have had an allergic reaction to a dye called ICG (indocyanine green) in the past
- People who were not asked to join the study before an unexpected lower bowel resection took place during surgery
- People who did not end up having the lower bowel section removed during the operation
- People whose lower bowel removal was related to a different type of gynaecological cancer (other than the cancers listed above)
- People who require a permanent colostomy (a permanent opening in the abdomen for waste removal, rather than having the bowel reconnected)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mario Leitao, MD, Memorial Sloan Kettering Cancer Center
Phone: 212-639-3987
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Reduction of the risk of 30-day postoperative anastomotic leak at the site of rectosigmoid resection, compared with standard intraoperative assessment alone
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.